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Abstract
A study was conducted between November, 2007 and April, 2008 to evaluate the 
anti-rabies activity of the leaf of Salix subserrata and root of Silene macroselen 
which are traditionally used for the treatment of rabies in Bereh-Aleltu Woreda, 
North Shewa, Central Ethiopia. The study involved oral administration of crude 
extracts of Salix subserrata and Silene macroselen to Pasteur Virus (PV) strain 
rabies virus infected mice which were assigned into three treatment and one nega-
tive control groups. Chloroform, methanol 80% and aqueous extracts of the study 
plants were prepared using maceration technique. Statistical analysis was per-
formed by one-way analysis of variance tests coupled to least significant difference 
to compare result between treatment and positive control groups. Of the 6 crude 
extracts, chloroform and methanol 80% of Silene macroselen and chloroform and 
aqueous of Salix subserrata were found to increase the survival time of mice signifi-
cantly (P< 0.05). Nevertheless, aqueous extract of Silene macroselen and methanol 
80% extract of Salix subserrata did not exhibit a significant effect on the survival 
time. 1 day and 2 days treatment groups of the chloroform extract of S. macroselen 
indicated significant difference on the survival time from the positive control (P< 
0.05). The chloroform and aqueous extracts of S. subserrata and the methanol 80 
% extract of S. macroselen in their 1 day and 3 days treatment showed significant 
difference on survival time from the positive control group (P< 0.05). The results 
obtained from the present work suggest good correlation between traditional ther-
apeutic uses and the in vivo anti-rabies activity. Further characterization of the 
active ingredients would reveal useful compounds.
Keywords: Anti-rabies, Ethno-pharmaceutical, Mice model, PV strain, Salix 
subserrata, Silene macroselen
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Introduction
Rabies is a fatal viral zoonosis, which causes encephalitis in warm-blooded ani-
mals and humans. Rabies virus belongs to the order Mononegavirales, family 
Rhabdoviridae, and genus lyssavirus. Despite the invention and application of 
the first rabies vaccine by Louis Pasteur in 1885, human rabies, is still a prob-
lem in the world (Hendekli, 2005).
In most developing countries like Ethiopia nervous tissue vaccines are admin-
istered to the people after exposure to rabid animal. These vaccines have side 
effects with neuroparalytic complications and should be replaced by modern 
cell culture vaccines (Hemachudha et al., 2002). Unlike other infective agents, 
viruses totally depend on the cell they infect for their multiplication and 
survival. Thus, a prospective antiviral agent may also damage the cell that 
houses the organism, and is therefore undesirable. It is for this main reason 
that many afflictions of viral origin still remain elusive to therapeutic and/or 
prophylactic means, though there have been very successful vaccines for the 
control of certain viral diseases. Therefore, the search for antiviral agents that 
are selectively virucidal remains a goal. In this regard, the potential of medici-
nal plants, especially those employed in indigenous medicine, is believed to be 
very significant in providing novel antiviral compounds or prototypes (Dawit 
Abebe et al., 2003).
The World Health Organization estimates that at least 80 % of the populations 
in most developing countries rely for their primary health care on traditional 
forms of health care (WHO, 1993). Recognizing this fact and the fact that mod-
ern health care system alone could not meet the health needs of the entire 
population of the world, the policy of urging its member states to promote and 
integrate traditional medicine into their national health care systems was 
launched by WHO in 1978 (WHO, 1996). The treatments recommended for 
people bitten by rabid animals mainly dogs have been recorded in many Ethio-
pian medical books since the early 17th century (Sterleyn, 1968 cited by Fekadu 
Mekonnen, 1982). The employment of a wide variety of supposed cures by early 
traditional practitioners illustrated the well-established character of the tradi-
tional pharmacopoeia in the country (Richard, 1990). 
In Ethiopia, traditional medicine practices are deep-rooted and continue to be 
widely used among both rural and urban population. This wide spread use of 
traditional medicine in the country could be attributed to cultural acceptabili-
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ty, efficacy against certain type of diseases, physical accessibility and economic 
affordability as compared to modern medicine (Tilahun  and Mirutse, 2007). 
The practice of traditional medicine for the control of rabies in most parts of 
Ethiopia is based on the use of plant medicines for many years. Several tradi-
tional herbs have been formulated by traditional healers to treat human and 
animal rabies. The fact that herbal medicines have been employed for such a 
long time does not guarantee their efficacy and safety. Thus, pharmacological 
screening of medicinal plants remains important to provide the society with 
new, effective and safe drugs. The present study was, therefore, carried out to 
evaluate the anti-rabies activities of the claimed medicinal plants and encour-
age further research on the claimed plants if they are proven to have antiviral 
activity.
Materials and Methods 
The leaves of Salix subserrata and the roots of Silene macroselen used by tradi-
tional healers were collected from Bereh-Aleltu Woreda, North Showa Zone of 
Oromia Regional State between December, 2007 and January, 2008. Botanical 
identification and authentication was done using the manual of the Depart-
ment of Drug Research of the Ethiopian Health and Nutrition Research Insti-
tute (DDR-EHNRI), (Dawit Abebe et al., 2003). 
Processing and Extraction
The collected plant materials were brought to the DDR-EHNRI and stayed 
overnight. The specimens were processed and extracted according to the proce-
dures given by Asfaw Debella (2002). Briefly, garbling was performed following 
collection before drying and processing of the roots and leaves of Silene mac-
roselen and Salix subserrata respectively. The plant materials were chopped 
into smaller pieces before drying. Then, they were dried indoors without expo-
sure to sunlight for 1 month. The dried plant materials were grounded to vari-
ous degrees of fineness depending on their botanical structures. The grounded 
plant materials were weighed by sensitive digital weighing balance (scientech 
balance) and successively extracted in chloroform, methanol 80% and aqueous 
solvents in Erlenmeyer flask.
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In Vivo Anti-rabies Screening of Crude Extracts 
Experimental Animals
Male and female Swiss albino mice weighing 20-25 g were used for the in vivo 
anti- rabies drug trial. All the animals used for this experiment were bred in 
a standard laboratory animal house of the Ethiopian Health and Nutrition 
Research Institute (EHNRI.) After the mice were obtained from the laboratory 
animal unit, they were housed in a metal cage. As described by Gebrie Endalk 
et al., 2005 with some modification. Six mice were used in each group and each 
animal was used only for one experiment.
Experimental Protocols (Table 2)
The animals were randomly assigned into three treatment groups and three 
controls (one positive control and two negative controls). Though mice were as-
signed randomly, each group contained only male or female.
Table 2: Experimental Design of the study 
Group No of mice/group Administration/dose/freq     
I 6 *PV 0.25ml, one time, 10- 3
II 6 80mg/kg extract, one time
III** 6 *PV 0.25ml + 80mg/kg extract for 1day
IV** 6 *PV 0.25ml + 80mg/kg extract for 2 days  
V** 6 *PV 0.25ml + 80mg/kg extract for 3days
VI 6 Polysorbate-80, 1ml ,one time
* Pasteur Virus strain 
**The treatment groups
Dilution of the Extracts
The crude extracts were diluted before administration to the mice. Organic 
extracts (chloroform and methanol 80% extracts) were diluted using a 4% 
Polysorbate-80 solvent. Aqueous extracts were diluted using sterile distilled 
water. 
Rabies Virus Inoculation 
PV strain rabies virus was obtained from Zoonoses Research Team of the -EH-
NRI. The stock PV strain rabies virus (10-1 rabbit brain suspension) was dilut-
ed using sterile distilled water to 10-3 suspension. Each mouse in the treatment 
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groups and positive control was injected 0.25ml of 10-3 rabbit brain suspension 
intramuscularly into gastronemicus muscle (Meslin, 1996).
Extract Administration
After virus inoculation, the mice were allowed to stay in their respective cages 
for about 1 hour so as to make them calm. Then, the extracts were orally ad-
ministered to the mice in the treatment groups and negative control (Group 
II) (Table 2). Administration of the extract was done by using an intra-gastiric 
needle based on the animal’s body weight in 1ml vehicle. 
Determination of Mean Survival time 
The animals were monitored daily for the sign of paralysis and mortality for 
about 50 days after inoculation of the virus. Death was recorded for each mouse 
in the treatment and control groups throughout the follow up period. The mean 
survival time (MST) for each group was calculated as (Birhanu Mengstie, 2008, 
unpublished).
     MST = Sum of survival time of each mice in a group
                 Initial mice number in a group
Acute Toxicity Test
All extracts were examined for acute toxicity by administering an oral dose 
ranging from 0.5 mg/ml to 2mg/ml for 15 mice per extract. Mortality in each 
group within 24 hours was recorded. The animals were observed for about 7 
days for any sign of delayed toxicity (Miller and Tainter, 1944).
Statistical Analysis 
Data were analyzed using SPSS version 11.5 for windows software. Statisti-
cal analysis was undertaken by one-way analysis of variance (ANOVA) tests 
coupled to least significant difference (LSD) to compare results among differ-
ent treatment groups and between treatment and control groups. Mean sur-
vival time were calculated by Microsoft-excel 2003 and expressed as mean ±SD 
for each treatment and control groups. The result was considered statistically 
significant at 95% confidence level and P-value<0.05.
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Result 
Parts of plants used by traditional healers to treat rabies are indicated in Ta-
ble 1.
Table1: Parts of plants reported as used by traditional healers for treatment of rabies 
in Bereh-Aleltu woreda
Family Species Local 
name





Salicaceae S. subserrata Aleltu Leaves Tree Liquid Oral 
Caryophyllaceae S. macroselen Wegert Root Herbs Liquid Oral 
 
Effect of crude extracts on survival time
Table 2 and 3 show   a significant (P<0.05) effect of crude extracts of S. mac-
roselen and S. subserrata on survival time, respectively. Treatment with crude 
extracts significantly increases the survival time.
Table 2: Effect of crude extract of   S. macroselen root on mean survival time
Extracts/dose Group Treatment 
frequency(day)
Survival time(day)
Chloroform III    1 32±8.94
     80mg/kg IV    2 27.67±11.8
V    3 22.8±13.17
PV only* I    1 12±0.82
     0.25ml
     80%MeOH III   1 26.83±12.97
     80mg/kg IV   2 22.83±13.22
V   3 24±12.05
PV only* I   1 8.83±0.69
     0.25ml
Aqueous III   1 22.67±13.36
     80mg/kg IV   2 19.17±11.96
V   3 19.33±11.79
PV only* I   1 9.67±0.94
     0.25ml
N=6; survival time=mean ± SD 
*Included to compare with the treatment groups
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Table 3: Effect of crude extract of   S. subserrata leaves on mean survival time
Extracts/dose Group Treatment 
frequency(day)
Survival time(day)
Chloroform III 1 50 ±0
            80mg/kg IV 2 6.5 ±1.89
V 3 43 ± 15.65
PV only* I 1 9 ±0.57
          0.25ml
80%MeOH III 1  7.83 ±0.89
            80mg/kg IV 2 16.67 ±14.92
V 3 10 ±0.57
PV only* I 1 8.83 ±1.86
            0.25ml
Aqueous III 1 31.83±9.31
             80mg/kg IV 2 24±12.12
V 3 27.33±12.25
PV only* I 1 11.83±1.34
             0.25ml
N=6; survival time=mean ± SD 
* Included to compare with the treatment groups
Comparisons of treatment groups with positive control 
on survival time for each crude extract
Salix subserrata 
Chloroform crude extract 
As shown in table 4, 1day and 3 days treatment groups with the chloroform 
extract are significantly associated on the survival time. Therefore, 1 day and 
3 days treatment exhibited anti- rabies activity.
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Table 4: Multiple comparisons of positive control and treatment 
groups for chloroform extract of S. subserrata




 GROUP I=PV rabies 
virus 
 GROUP III=PV rabies 
virus  
  + 
 1 day treatment
 GROUP IV=PV rabies 
virus  
  + 
 2 day treatment
 GROUP V=PV rabies 
virus  
  + 
 3 day treatment
 I IIII -41.0000* .000
 IV 2.5000 .622
 V -34.0000* .000
III I 41.0000* .000
 IV 43.5000* .000
 V 7.0000 .176
IV I -2.5000 .622
 III -43.5000* .000
 V -36.5000* .000
V I 34.0000* .000
 III -7.0000 .176
 IV 36.5000* .000
* The mean difference is significant at the 0.05 level
i) Methanol 80% crude extract 
Methanol 80 % extract did not show any statistical significant association on 
the survival time (table5). 
Table 5:  Multiple comparisons of positive control and treatment groups for methanol 
80% extract of S. subserrata
GROUP (a) GROUP (b)
Mean Difference  
(a-b) Sig.
Where:
     GROUP I=PV rabies virus
     GROUP III=PV rabies virus 
                        +
     1 day treatment
     GROUP IV=PV rabies virus 
                         +
     2 day treatment
     GROUP V=PV rabies virus 
                          +
     3 day treatment
I III 1.0000 .836
 IV -7.8333 .116
 V -1.1667 .809
III I -1.0000 .836
 IV -8.8333 .079
 V -2.1667 .655
IV I 7.8333 .116
 III 8.8333 .079
 V 6.6667 .178
V I 1.1667 .809
 III 2.1667 .655
 IV -6.6667 .178
The mean difference is significant at the 0.05 level.
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i) Aqueous crude extract
As can be seen in table 6, there is a statistical significance difference on the 
survival time between the control and the treatment groups.
Table 6: Multiple comparisons of positive control and treatment groups for aqueous 
extract of S. subserrata
GROUP (a) GROUP (b)
Mean Difference 
(a-b) Sig.
             Where:
     GROUP I=PV rabies virus
     GROUP III=PV rabies virus 
                         +
     1 day treatment
     GROUP IV=PV rabies virus 
                         +
     2 day treatment
     GROUP V=PV rabies virus 
                          +
     3 day treatment
I III -20.0000* .004
 IV -12.1667 .064
 V -15.5000* .021
III I 20.0000* .004
 IV 7.8333 .222
 V 4.5000 .477
IV I 12.1667 .064
 III -7.8333 .222
 V -3.3333 .597
V I 15.5000* .021
 III -4.5000 .477
 IV 3.3333 .597
* The mean difference is significant at the 0.05 level.
Silene macroselen
i) Chloroform crude extract
The third and fourth treatment groups have shown a reliable difference on 
survival time from the control group (table 7). Third group did show greater 
anti-rabies activity as compared to the fourth group.
 
Asefa Deressa, et al.
Ethiop. Vet. J., 2010, 14 (2), 1-1610
Table 7: Multiple comparisons of positive control and treatment groups for chloroform 





     GROUP I=PV rabies virus
     GROUP III=PV rabies virus 
                        +
     1 day treatment
     GROUP IV=PV rabies virus 
                        +
     2 day treatment
     GROUP V=PV rabies virus 
                          +
     3 day treatment
I III -20.0000* .005
 IV -15.6667* .021
 V -10.8333 .100
III I 20.0000* .005
 IV 4.3333 .498
 V 9.1667 .159
IV I 15.6667* .021
 III -4.3333 .498
 V 4.8333 .450
V I 10.8333 .100
 III -9.1667 .159
 IV -4.8333 .450
* The mean difference is significant at the 0.05 level.
ii)  Methanol 80% crude extract
The survival time is significantly increased in 1day and 3 days treatment 
groups as indicated in table 8.
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Table 8: Multiple comparisons of positive control and treatment groups for methanol 
80% extract of S. macroselen
GROUP (a) GROUP (b)
Mean Difference  
(I-J) Sig.
Where:
     GROUP I=PV rabies virus
     GROUP III=PV rabies virus 
                        +
     1 day treatment
     GROUP IV=PV rabies virus 
                         +
     2 day treatment
     GROUP V=PV rabies virus 
                          +
     3 day treatment
I III -18.0000* .018
 IV -14.0000 .059
 V -15.1667* .042
III I 18.0000* .018
 IV 4.0000 .574
 V 2.8333 .690
IV I 14.0000 .059
 III -4.0000 .574
 V -1.1667 .869
V I 15.1667* .042
 III -2.8333 .690
 IV 1.1667 .869
* The mean difference is significant at the 0.05 level
iii) Aqueous crude extract
Any treatment group of the aqueous extract did not show a significant associa-
tion on survival time as compared to the positive control (table 9).
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Table 9: Multiple comparisons of positive control and treatment groups for aqueous 
extract of S. macroselen





     GROUP I=PV rabies virus
     GROUP III=PV rabies virus 
                         +
     1 day treatment
     GROUP IV=PV rabies virus 
                          +
     2 day treatment
     GROUP V=PV rabies virus 
                          +
     3 day treatment
I III -13.0000 .070
 IV -9.5000 .177
 V -9.6667 .170
III I 13.0000 .070
 IV 3.5000 .612
 V 3.3333 .629
IV I 9.5000 .177
 III -3.5000 .612
 V -.1667 .981
V I 9.6667 .170
 III -3.3333 .629
 IV .1667 .981
* The mean difference is significant at the 0.05 level.
Acute toxicity 
No mortality was observed with the extract given up to 80mg/kg. No visible 
signs of delayed toxicity were also observed within 7 days in surviving mice.
General information about these plants is listed in Table 1. 
Discussion
S. maroselene and S. subserrata have never been evaluated for anti-rabies ac-
tivity in the laboratory before, and thus, the present study was the first to 
evaluate the above plants in mice model. Some extracts of the plants showed 
anti-rabies activity. Similarly, Muller and colleagues (2007) found leaves and 
flowers of Alamanda schottii to have anti-rabies activity. Four of the six crude 
extracts, namely chloroform and methanol 80 % extracts of S. macroselen and 
chloroform and aqueous extracts of S. subserrata, did show a significant anti-
rabies activity. Methanol extracts of Alamanda schottii showed anti-rabies 
activity (Muller et al., 2007). However, the anti-viral activity resided only in 
aqueous rather than in ethanol extracts of Nepeta nepetella leaves (Abad et al., 
2000). On the other hand, in the current study, neither the aqueous extract of 
 
Asefa Deressa, et al.
Ethiop. Vet. J., 2010, 14 (2), 1-16 13
S. macroselen nor methanol 80% extract of S. subserrata did show significant 
anti-rabies activity.  
The 1 day and 2 days treatment groups of the chloroform extract of S. mac-
roselen did show a significant difference on their survival time from the control 
group than the 3 days treatment group. This might be attributed to the estab-
lished fact that the percentage of population affected increases as the dose is 
raised (Goldan et al., 2005).
The chloroform and aqueous extracts of S. subserrata and the methanol 80 
% extract of S. macroselen in their 1 day and 3 days treatment did show sig-
nificant difference on survival time from the control group. Nevertheless, they 
did not show any statistical difference in their 2 days treatment groups. This 
might be due to the fact that all mice admitted to Group II were males. How-
ever, Gochfeld (2007) suggested that female rats required half the dose of bar-
biturates, compared to males, to induce sleep, and the duration of sleep was 
substantially longer in females given the same dose as males. 
In the current investigation, anti-rabies activity of S. macroselen was detected 
from the chloroform and methanol 80% crude extracts. Though no identifica-
tion of secondary metabolites responsible for this activity was done, the ac-
tive compound(s) is/are more of non-polar. However, that of S. subserrata was 
observed from the chloroform and aqueous crude extracts, which indicates 
the responsible secondary metabolites are from both non-polar and polar com-
pounds. Medicinal plants have a variety of chemical constituents, which have 
the ability to inhibit the replication cycle of various types of DNA or RNA vi-
ruses (Jassim and Naji, 2003).
In the investigated plants’ crude extracts, aqueous of S. macroselen and meth-
anol 80 % of S. subserrata did not show a significant anti-rabies activity. How-
ever, negative results do not mean absence of bioactive constituents nor that 
the plant is inactive. Active compound(s) may be present in insufficient quanti-
ties in the crude extracts to show activity with the dose levels employed (Tay-
lor et al., 2001). Alternatively, if the active principle is present in high enough 
quantities, there could be other constituents exerting antagonistic effects or 
negating the positive effects of the bioactive agents (Jager et al., 1996).
Generally, the results obtained are in line with the traditional uses of the 
plants as crude anti-rabies drugs. However, traditional healers seldom use a 
single plant in their extracts. In many cases, the therapeutic benefits are at-
tributed to the consumption of plant mixtures in which different plant parts 
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are prepared and/or consumed in combination or in sequence (Etikin, 1986; 
Taylor et al., 2001).  
In view of the significant number of plant extracts that have yielded positive 
results in the present study, seems reasonable to conclude that there are prob-
ably numerous kinds of anti-rabies agents in these materials. It is also rec-
ommendable to make further investigation of the active ingredients to reveal 
more useful compounds.
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